EYEPOINT PHARMACEUTICALS INC's ticker is and the CUSIP is 30233G950. A total of 3 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $27,000 | -43.8% | 36,000 | -23.2% | 0.00% | – |
| Q1 2020 | $48,000 | -52.9% | 46,900 | -28.4% | 0.00% | -100.0% |
| Q4 2019 | $102,000 | -20.3% | 65,500 | -7.2% | 0.00% | 0.0% |
| Q3 2019 | $128,000 | +42.2% | 70,600 | +29.3% | 0.00% | 0.0% |
| Q2 2019 | $90,000 | +181.2% | 54,600 | +203.3% | 0.00% | – |
| Q1 2019 | $32,000 | +357.1% | 18,000 | +361.5% | 0.00% | – |
| Q4 2018 | $7,000 | -53.3% | 3,900 | -4.9% | 0.00% | – |
| Q3 2018 | $15,000 | – | 4,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 3,900 | $7,000 | 0.00% |
| SIMPLEX TRADING, LLC | 10 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |